Thomas E. Smithgall
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
Papers in
- Virology 43
- HIV Research and Treatment 43
- Hematology 37
- Chronic Myeloid Leukemia Treatments 30
- Co-authors
- John R. Engen (32 shared papers)T.M. Penning (10 shared papers)Edwina C. Lerner (12 shared papers)Scott D. Briggs (9 shared papers)Lori A. Emert‐Sedlak (22 shared papers)Matthew B. Wilson (5 shared papers)Anthony P. Schiavone (6 shared papers)Jerrod A. Poe (8 shared papers)
- Journals
- Journal of Biological Chemistry (39 papers)Biochemistry (16 papers)Journal of Molecular Biology (9 papers)PLoS ONE (8 papers)Proceedings of the National Academy of Sciences (5 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Thomas E. Smithgall
169 papers receiving 8.0k citations
Peers
Comparison fields: 5 of 130
- Virology 1.1k
- Hematology 1.1k
- Oncology 1.8k
- Immunology 1.5k
- Genetics 661
Countries citing papers authored by Thomas E. Smithgall
This map shows the geographic impact of Thomas E. Smithgall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Smithgall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Smithgall more than expected).
Fields of papers citing papers by Thomas E. Smithgall
This network shows the impact of papers produced by Thomas E. Smithgall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Smithgall. The network helps show where Thomas E. Smithgall may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Smithgall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. | 1997 | 334 |
| 2 | 2011 | 236 | |
| 3 | 2009 | 221 | |
| 4 | 1996 | 210 | |
| 5 | 1997 | 186 | |
| 6 | 2013 | 164 | |
| 7 | 2003 | 155 | |
| 8 | 2008 | 151 | |
| 9 | 2002 | 149 | |
| 10 | 2000 | 147 | |
| 11 | 2004 | 144 | |
| 12 | 1996 | 131 | |
| 13 | 2006 | 128 | |
| 14 | 2015 | 124 | |
| 15 | 2006 | 123 | |
| 16 | 1986 | 123 | |
| 17 | 2001 | 122 | |
| 18 | 2000 | 117 | |
| 19 | 2002 | 115 | |
| 20 | 1988 | 108 |
About Thomas E. Smithgall
Thomas E. Smithgall is a scholar working on Virology, Hematology, Molecular Biology, Infectious Diseases and Oncology, having authored 171 papers that have together received 8.2k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (43 papers), HIV Research and Treatment (43 papers), HIV/AIDS drug development and treatment (31 papers), Chronic Myeloid Leukemia Treatments (30 papers), Cytokine Signaling Pathways and Interactions (19 papers), Chronic Lymphocytic Leukemia Research (16 papers), Protein Structure and Dynamics (16 papers) and Enzyme Structure and Function (16 papers). The work is most often cited by research in Virology (1.1k citations), Hematology (1.1k citations), Oncology (1.8k citations), Immunology (1.5k citations) and Genetics (661 citations). Thomas E. Smithgall has collaborated with scholars based in United States, Japan and China. Frequent co-authors include John R. Engen, T.M. Penning, Edwina C. Lerner, Scott D. Briggs, Lori A. Emert‐Sedlak, Matthew B. Wilson, Anthony P. Schiavone, Jerrod A. Poe, Richard Jove and Ronald G. Harvey. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Journal of Molecular Biology, PLoS ONE and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.